Literature DB >> 30061227

Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer.

Kuo-Wang Tsai1,2,3, Wei-Ting Kuo4,5,6, Shaw-Yeu Jeng7,5.   

Abstract

BACKGROUND/AIM: Bladder cancer is the most common malignancy involving the urinary system. The mortality rate in late stages remains high, thus the development of effective biomarkers for diagnosis or prognosis is required in order to improve patient survival rates. Tight junction protein 1 (TJP1) is a membrane-associated protein that helps modulate cell-cell contact. However, the role of TJP1 in bladder cancer progression remains unclear.
MATERIALS AND METHODS: The expression levels of TJP1 and miR-455-5p were examined by analyzing The Cancer Genome Atlas database. The biological role of TJP1 and miR-455-5p were assessed in T24 cells with siTJP1 or miR-455-5p mimics transfection, respectively.
RESULTS: High levels of expression of TJP1 were significantly correlated with poor lymph node metastasis (pN stage; p=0.004). Knockdown of the TJP1 gene expression led to significant decrease of the growth and invasion of T24 cells. Using a bioinformatics approach, miR-455-5p was shown to suppress TJP1 expression by directly targeting its 3' prime untranslated region in bladder cancer cells. The ectopic expression of miR-455-5p revealed that bladder cancer cell migration, invasion, and proliferation were significantly suppressed.
CONCLUSION: In summary, our results indicate that dysfunction of the miR-455-TJP1 axis is involved in bladder cancer cell growth and metastasis. These findings highlight potential therapeutic targets or putative biomarkers for bladder cancer. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Bladder cancer; TJP1; miR-455

Mesh:

Substances:

Year:  2018        PMID: 30061227     DOI: 10.21873/anticanres.12765

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer.

Authors:  Xue-Qi Liu; Xin-Rong Shao; Ye Liu; Zhao-Xia Dong; Sze-Hoi Chan; Yuan-Yuan Shi; Shu-Na Chen; Lin Qi; Li Zhong; Yue Yu; Ting Lv; Peng-Fei Yang; Li-Yan Li; Xiao-Bin Wang; Xu-Dong Zhang; Xin Li; Wenxue Zhao; Lalit Sehgal; Miao Li; Xing-Ding Zhang
Journal:  Oncogene       Date:  2021-11-15       Impact factor: 8.756

2.  High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging.

Authors:  Yi-Chen Lee; Kuo-Wang Tsai; Jia-Bin Liao; Wei-Ting Kuo; Yu-Chan Chang; Yi-Fang Yang
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

3.  LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.

Authors:  Huifeng Bi; Zhenhua Shang; Chunsong Jia; Jiangtao Wu; Bo Cui; Qi Wang; Tongwen Ou
Journal:  Onco Targets Ther       Date:  2020-11-04       Impact factor: 4.147

4.  microRNA-324 plays an oncogenic role in bladder cancer cell growth and motility.

Authors:  Kuo-Wang Tsai; Wei-Ting Kuo; Shaw-Yeu Jeng
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.